Luteinising hormone-releasing hormone (LHRH), also known as gonadotropin-releasing hormone (GnRH) and luliberin, is a key hormone associated with controlling functions of reproductive organs in both males and females. Anti-LHRH vaccines can produce immunity against LHRH resulting in castration effects, which can be applied for contraception in animals or the treatment of hormone-dependent diseases. A selfadjuvanting delivery system for peptide-based vaccines is a safe and effective approach to address the problem of toxic adjuvants used in animals and humans. Lipid core peptide (LCP) provides self-adjuvanting properties and is recognised to interact with specific Tolllike receptors on antigen presenting cells. Lipidic adjuvant, in conjugation with polylysine or a carbohydrate core in a multiple antigen peptide (MAP) system, has shown significant contribution to enhance the immunogenicity of small antigens like peptides and these approaches of modification have been adapted to reder immunogenicity studies.One of the approaches is use carbohydrates to induce immunity is an effective and new strategy if the obstacles associated with poor quality of antibody response are overcome.Modified monosaccharaides such as glucose or galactose scaffold offer MAP system-like properties that provide attachment sites for conjugation of multiple identical epitopes.Moreover, different carbohydrate groups provide different orientations for the side chains.This structural conformation-related effect may augment immunity in vaccination. A carbohydrate-based anti-LHRH vaccine candidate was synthesised with a galactose scaffold. D-galactose was modified as a scaffold to provide conjugation sites for the attachment of four LHRH epitopes. However, due to low efficiency of the method, the synthesis resulted in a low yield of galactose scaffold, therefore sufficient final vaccine candidate was not achieved to be used in immunological studies.Another approache of modification uses three components to form four branched vaccine Overall, this project unravelled the ability of different applied synthetic strategies and delivery systems to stimulate anti-LHRH immune response, and contributes to the development of future immunocontraceptives or vaccines against hormone-dependent cancers.iv